الصفحة الرئيسية>>Signaling Pathways>> Others>>tetramethyl Nordihydroguaiaretic Acid

tetramethyl Nordihydroguaiaretic Acid (Synonyms: EM-1421,M4N,Tetrameprocol,tetramethyl NDGA,TMNDGA)

رقم الكتالوجGC14778

حمض رباعي ميثيل نورديهيدروغواياريتيك هو مشتق اصطناعي من حمض نوردهيدروجواياريتيك ومثبط غير انتقائي ليبوكسجيناز.

Products are for research use only. Not for human use. We do not sell to patients.

tetramethyl Nordihydroguaiaretic Acid التركيب الكيميائي

Cas No.: 24150-24-1

الحجم السعر المخزون الكميّة
50mg
21٫00
متوفر
100mg
38٫00
متوفر
500mg
151٫00
متوفر
1g
265٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tetramethyl Nordihydroguaiaretic acid (TMNDGA) is a synthetic derivative of NDGA (Nordihydroguaiaretic acid), a non-selective lipoxygenase inhibitor. TMNDGA showed the strongest anti-HIV activity.

In vitro: In Vero cells, TMNDGA inhibited Sp1 transcription factor binding at the HIV long terminal repeat promoter and at the α-ICP4 promoter with IC50 values of 11 and 43.5 μM, respectively. The IC50 of TMNDGA varied between 11.7 and 4 μM in 10 passages of HSV-1 and 4 passages of HSV-2 [2]. TMNDGA inhibited Sp1-dependent Cdc2 gene expression. In M4N-treated transformed C3 cells, TMNDGA induced growth arrest and apoptosis by suppressing Sp1-dependent Cdc2 and survivin gene expression giving rise to its antitumorigenic activity [3]. TMNDGA treatment suppressed expression of the Sp1-dependent survivin gene. In transiently and stably survivin-transfected C3 cells, TMNDGA reduced caspase-3 activation by 50% and 75%, respectively [3]. TMNDGA inhibited the growth of a number of tumor cell lines by inducing apoptosis in a non-schedule-dependent manner [4]. TMNDGA inhibited the synthesis of DNA by melanoma cells and causes cell cycle arrest in G0/G1 and G2/M phases of the cell cycle [4].

In vivo: TMNDGA effectively inhibited the growth of human tumors in nude mice [5]. TMNDGA inhibited the growth of both murine and human melanomas and human colon cancer without apparent hepatic or renal toxicity [4]. In nude (nu/nu) mice bearing xenografts of human tumor types (Hep 3B, LNCaP, HT-29, MCF7, and K-562), treatment with TMNDGA (i.v. or i.p.) down-regulated Cdc2 and survivin genes expression [5].

References:
[1] Hwu J R, Tseng W N, Gnabre J, et al.  Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation[J]. Journal of medicinal chemistry, 1998, 41(16): 2994-3000.
[2] Chen H, Teng L, Li J N, et al.  Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA[J]. Journal of medicinal chemistry, 1998, 41(16): 3001-3007.
[3] Chang C C, Heller J D, Kuo J, et al.  Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression[J]. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(36): 13239-13244.
[4] Lambert J D, Meyers R O, Timmermann B N, et al.  Tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo[J]. Cancer letters, 2001, 171(1): 47-56.
[5] Park R, Chang C C, Liang Y C, et al.  Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors[J]. Clinical Cancer Research, 2005, 11(12): 4601-4609.

مراجعات

Review for tetramethyl Nordihydroguaiaretic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for tetramethyl Nordihydroguaiaretic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.